Variant report
| Variant | esv3475019 |
|---|---|
| Chromosome Location | chr11:107784342-107790340 |
| allele | n/a |
| Outlinks | Ensembl UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs74715320 | chr11:107784349-107784350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs149703813 | chr11:107784399-107784400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs572489840 | chr11:107784404-107784405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs573942596 | chr11:107784410-107784411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs187587216 | chr11:107784433-107784434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs559529710 | chr11:107784450-107784451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs199705881 | chr11:107784454-107784455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs200805862 | chr11:107784456-107784457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs201641381 | chr11:107784457-107784458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs200167134 | chr11:107784458-107784459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs376274822 | chr11:107784459-107784460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs369291262 | chr11:107784460-107784461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs116265404 | chr11:107784468-107784469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs548868085 | chr11:107784503-107784504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs192032743 | chr11:107784527-107784528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs567082046 | chr11:107784545-107784546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs200685876 | chr11:107784575-107784576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs144778158 | chr11:107784576-107784577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs554900460 | chr11:107784611-107784612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs140114462 | chr11:107784615-107784616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs571296809 | chr11:107784642-107784643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs11212435 | chr11:107784789-107784790 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 23 | rs145579873 | chr11:107784863-107784864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs543674869 | chr11:107784871-107784872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs147736961 | chr11:107784918-107784919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs493342 | chr11:107784942-107784943 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 27 | rs182665960 | chr11:107784962-107784963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs552952068 | chr11:107785025-107785026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs576684628 | chr11:107785026-107785027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs568359894 | chr11:107785028-107785029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs537620851 | chr11:107785029-107785030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs185343976 | chr11:107785032-107785033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs190237432 | chr11:107785039-107785040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs73548901 | chr11:107785083-107785084 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 35 | rs535618703 | chr11:107785121-107785122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs376532572 | chr11:107785128-107785129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs80187690 | chr11:107785130-107785131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs61906916 | chr11:107785131-107785132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs142250052 | chr11:107785178-107785179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs542479413 | chr11:107785189-107785190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs151261058 | chr11:107785192-107785193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs531525478 | chr11:107785208-107785209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs182820153 | chr11:107785228-107785229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs4561176 | chr11:107785241-107785242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs111719045 | chr11:107785249-107785250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs371530913 | chr11:107785268-107785269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs532229445 | chr11:107785273-107785274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs187468561 | chr11:107785301-107785302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs373719255 | chr11:107785308-107785309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs565638170 | chr11:107785312-107785313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Variant related diseases (count:94)
| Disease | PMID | Source |
|---|---|---|
| Medulloblastoma | 21979893 | CNVD |
| Gastric cancer | 17908304 | CNVD |
| Multiple myeloma | 20724749 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Autism | 22495311 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Cancer | 21637783 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Chronic lymphocytic leukemia | 21795749 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Neuroblastoma | 21484798 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Oral cancer | 21386901 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 20837533 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Cervical cancer | 21063398 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Neuroblastoma | 18923524 | CNVD |
| Neuroblastoma | 18664255 | CNVD |
| Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
| Multiple myeloma | 17077331 | CNVD |
| Neuroblastoma | 17533364 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Cancer | 16751803 | CNVD |
| Seminomas | 18059402 | CNVD |
| Cervical cancer | 21062161 | CNVD |
| Esophageal squamous carcinoma | 18350619 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Acute lymphoblastic leukemia | 21339820 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Cancer | 22429812 | CNVD |
| Breast cancer | 16608533 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Melanoma | 18172304 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Basal cell lymphoma | 17053054 | CNVD |
| Hepatocellular carcinoma | 16785998 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Breast cancer | 21958427 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| Breast cancer | 17133270 | CNVD |
| T-cell prolymphocytic leukemia | 17713554 | CNVD |
| Acute lymphoblastic leukemia | 21098271 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Breast cancer | 17603634 | CNVD |
| T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
| Basal cell lymphoma | 16790693 | CNVD |
| Chronic lymphocytic leukemia | 21670202 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Ovarian clear cell carcinoma | 19293255 | CNVD |
| Mental retardation | 19966786 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
| Intracranial aneurysm | 16715129 | CNVD |
| Ovine squamous-cell carcinoma | 17599052 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Follicular lymphoma | 17170743 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Ovarian cancer | 21720365 | CNVD |
| Chronic lymphocytic leukemia | 17805327 | CNVD |
| Glioblastoma multiforme | 22286061 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Chronic lymphocytic leukemia | 18922857 | CNVD |
| Neuroblastoma | 17327916 | CNVD |
| Esophageal adenocarcinoma | 18519675 | CNVD |
| Esophageal squamous carcinoma | 17470683 | CNVD |
| Mantle cell lymphoma | 19029149 | CNVD |
| Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
| Malignant melanoma | 17260012 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Prostate cancer | 16573809 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Obesity | 19966786 | CNVD |
| Renal cell carcinoma | 21668985 | CNVD |
| Cancer | 20164920 | CNVD |
| Acute lymphoblastic leukemia | 18458336 | CNVD |
| Attention deficit hyperactivity disorder | 19546859 | CNVD |
| Cancer | 20164919 | CNVD |
| Breast cancer | 22522925 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr11:107783600-107784400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
| 2 | chr11:107784000-107785000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
| 3 | chr11:107785000-107786400 | Enhancers | Placenta | Placenta |
| 4 | chr11:107786400-107787600 | Weak transcription | Placenta | Placenta |
| 5 | chr11:107787200-107787800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
| 6 | chr11:107787200-107787800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
| 7 | chr11:107787400-107787800 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
| 8 | chr11:107787600-107787800 | Enhancers | Primary B cells from peripheral blood | blood |
| 9 | chr11:107787600-107787800 | Bivalent Enhancer | Brain Angular Gyrus | brain |
| 10 | chr11:107787600-107787800 | Enhancers | Placenta | Placenta |
| 11 | chr11:107789000-107798400 | Weak transcription | Right Atrium | heart |
